跳至主要内容
临床试验/NCT07547917
NCT07547917Enrolling By Invitation不适用

Improving the Measurement of Neonatal High Blood Pressure Using the Boppli Device

Indiana University1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年4月30日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
30
试验地点
1
主要终点
Feasibility and agreement of Boppli to cuff based measurements

研究概览

简要总结

This study evaluates a new, non-invasive device (Boppli™) that continuously measures blood pressure in newborn infants. The study compares Boppli measurements to standard blood pressure cuff measurements to determine how well the device works and whether it improves identification of high blood pressure in infants in the neonatal intensive care unit (NICU). The study also includes follow-up through 1 year of age to understand longer-term outcomes.

详细描述

High blood pressure in newborn infants (neonatal hypertension) is increasingly recognized but remains difficult to diagnose. There is no single standard definition, and current blood pressure measurements rely on intermittent cuff-based methods. These cuff measurements can be affected by infant movement, agitation, and measurement technique, which may lead to inaccurate classification of blood pressure.

The Boppli™ device is a non-invasive monitoring system that uses a soft band placed on the infant to continuously measure blood pressure using pulse wave signals. Unlike standard cuffs, the device does not inflate and may reduce measurement-related variability.

This is a prospective observational study conducted in infants admitted to the NICU who are less than 5 kg and are at risk for high blood pressure or have clinical concern for elevated blood pressure. The study does not change clinical care, and Boppli measurements will not be used for medical decision-making.

The study has three parts:

Part 1: Feasibility and Comparison of Measurements Infants will wear the Boppli device for up to 72 hours while standard blood pressure cuff measurements are collected as part of routine care. Measurements from the two methods will be compared to evaluate how closely they agree. The study will also assess how easy the device is to use and how well it is tolerated by infants, families, and clinical staff.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

盲法说明

Care teams and providers will be aware of the infant's participation, as the Boppli device will be visible. However, as the Boppli measurements will not be used to impact clinical care, the device screen will be covered to minimize distraction. Nursing staff will periodically confirm proper connection and functioning of the device, without removing the screen cover except as necessary. The devices waveform is visible to ensure measurements are taken.

入排标准

年龄范围
0 Months 至 9 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Admitted to the neonatal intensive care unit (NICU)
  • Age 0 to 9 months at time of enrollment
  • Weight less than 5 kg
  • At risk for elevated blood pressure or with clinical concern for hypertension, -including but not limited to:
  • History of acute kidney injury or kidney disease
  • History of extracorporeal membrane oxygenation (ECMO)
  • Parent or legal guardian able to provide informed consent

排除标准

  • Currently receiving extracorporeal membrane oxygenation (ECMO)
  • Currently receiving any form of extracorporeal dialysis (e.g., continuous renal -replacement therapy)
  • Presence of a ventricular assist device
  • Congenital anomalies or clinical conditions that prevent placement of the Boppli™ device
  • For Part 2 only: infants not expected to survive hospitalization

结局指标

主要结局

Feasibility and agreement of Boppli to cuff based measurements

时间窗: 72 hours

Feasibility will be assessed by the proportion of successful blood pressure measurements obtained using the Boppli™ device during the monitoring period and user-reported ease of use. Agreement will be assessed by comparing measurements obtained from the Boppli™ device to those obtained from standard cuff-based measurements using paired measurements.

次要结局

  • Diagnostic accuracy of Boppli™ device for identification of elevated blood pressure(72 hours)
  • Agreement in classification of elevated blood pressure between Boppli™ and cuff measurements(72 hours)
  • User-reported feasibility and acceptability of the Boppli™ device(72-144 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Cara Slagle

Associate Professor

Indiana University

研究点 (1)

Loading locations...

相似试验

Measurement of High Blood Pressure Using Boppli | 临床试验